Systemic corticosteroids and the risk of venous thromboembolism in COPD patients: A nationwide study of 30.473 outpatients with severe-very severe COPD
E. Rastoder (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), J. Eklöf (Hellerup, Denmark), M. Saeed (Hellerup, Denmark), A. Svorre Jordan (Hellerup, Denmark), H. Meteran (Hellerup, Denmark), L. Tønnesen (Hellerup, Denmark), T. Biering-Sørensen (Hellerup, Denmark), A. Løkke (Aarhus, Denmark), N. Seershol (Copenhagen, Denmark), T. Lynghøj Nielsen (Hillerød, Denmark), J. Carlsen (Copenhagen, Denmark), J. Janner (Copenhagen, Denmark), N. Godtfredsen (Copenhagen, Denmark), U. Bødtger (Naestved, Denmark), C. Laursen (Odense, Denmark), O. Hilberg (Vejle, Denmark), F. Knop (Hellerup, Denmark), H. Priemé (Herlev, Denmark), V. Gottlieb (Hellerup, Denmark), J. Wilcke (Hellerup, Denmark), J. Stæhr Jensen (Hellerup, Denmark)
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Session: Insights into pulmonary embolism
Session type: Oral Presentation
Number: 2590
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Rastoder (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), J. Eklöf (Hellerup, Denmark), M. Saeed (Hellerup, Denmark), A. Svorre Jordan (Hellerup, Denmark), H. Meteran (Hellerup, Denmark), L. Tønnesen (Hellerup, Denmark), T. Biering-Sørensen (Hellerup, Denmark), A. Løkke (Aarhus, Denmark), N. Seershol (Copenhagen, Denmark), T. Lynghøj Nielsen (Hillerød, Denmark), J. Carlsen (Copenhagen, Denmark), J. Janner (Copenhagen, Denmark), N. Godtfredsen (Copenhagen, Denmark), U. Bødtger (Naestved, Denmark), C. Laursen (Odense, Denmark), O. Hilberg (Vejle, Denmark), F. Knop (Hellerup, Denmark), H. Priemé (Herlev, Denmark), V. Gottlieb (Hellerup, Denmark), J. Wilcke (Hellerup, Denmark), J. Stæhr Jensen (Hellerup, Denmark). Systemic corticosteroids and the risk of venous thromboembolism in COPD patients: A nationwide study of 30.473 outpatients with severe-very severe COPD. 2590
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Venous thromboembolic (VTE) disease in people with chronic obstructive pulmonary disease (COPD): A matched case-control study Source: International Congress 2015 – New observations in respiratory epidemiology Year: 2015
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations Source: Eur Respir J, 53 (4) 1900147; 10.1183/13993003.00147-2019 Year: 2019
The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020
Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021
Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study Source: Eur Respir J, 50 (1) 1700094; 10.1183/13993003.00094-2017 Year: 2017
Impact of patients’ setting on the prevalence of pulmonary embolism in acute exacerbation of COPD : a meta-analysis of observational studies. Source: International Congress 2017 – Pulmonary embolism Year: 2017
The risk of hyperkalemia in COPD and asthma patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients Source: Eur Respir J, 52 (5) 1800248; 10.1183/13993003.00248-2018 Year: 2018
Cardiovascular comorbidity in severe COPD patients Source: International Congress 2017 – Markers of COPD progression Year: 2017
Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013
Systemic inflammation and pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007
Underdiagnosis of COPD in hospitalized patients Source: Eur Respir J 2002; 20: Suppl. 38, 122s Year: 2002
Cardiovascular risk assessment in COPD patients with severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016
The incidence of chronic thromboembolic pulmonary hypertension (CTEPH): a 25-year population-based study Source: Eur Respir J 2003; 22: Suppl. 45, 462s Year: 2003
Pulmonary embolism in patients in hospital with a COPD exacerbation Source: ISSN=ISSN 1810-6838, ISBN=, page=283 Year: 2007
Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013
Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013
The effects of uncontrolled oxygen therapy in the ambulance on outcome of patients admitted with exacerbation of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2004 - Acute exacerbations and drug therapy in COPD Year: 2004